Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
101M
-
Number of holders
-
165
-
Total 13F shares, excl. options
-
91.9M
-
Shares change
-
+17M
-
Total reported value, excl. options
-
$1.28B
-
Value change
-
+$237M
-
Put/Call ratio
-
1.51
-
Number of buys
-
98
-
Number of sells
-
-61
-
Price
-
$13.93
Significant Holders of Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN) as of Q3 2024
204 filings reported holding DAWN - Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q3 2024.
Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN) has 165 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 91.9M shares
of 101M outstanding shares and own 90.73% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (7.87M shares), FMR LLC (7.41M shares), Atlas Venture Life Science Advisors, LLC (6.43M shares), VANGUARD GROUP INC (5.89M shares), BRAIDWELL LP (4.87M shares), BlackRock, Inc. (4.71M shares), FRANKLIN RESOURCES INC (3.87M shares), Fairmount Funds Management LLC (3.1M shares), Pictet Asset Management Holding SA (2.98M shares), and STATE STREET CORP (2.82M shares).
This table shows the top 165 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.